La Nación, a major Costa Rican news outlet, published several updates on April 13, 2026, covering healthcare and economic topics relevant to the country.
On April 13, 2026, La Nación reported: ” Mediante negociación confidencial, CCSS logra bajar precio de inmunoterapia contra el cáncer: el medicamento en que más gasta y por el que más amparos recibe https://t.co/qy83SHNd2Z”. The tweet highlights that the Costa Rican Social Security Fund (CCSS) successfully negotiated a confidential deal to reduce the price of a cancer immunotherapy drug. This medication is identified as both the most expensive for the institution and the subject of frequent legal appeals from patients seeking access.
Later in the day, La Nación shared another update concerning medical oversight: ” Tres mujeres se operaron con la misma doctora a finales de año; ahora la denuncian ante el Colegio de Médicos https://t.co/UVBZnsHAFd”. According to this post, three women who underwent surgery with the same doctor at the end of last year have now filed complaints against her with Costa Rica’s national Medical Board.
The publication also addressed currency issues with an informational post: ” Tipo de cambio del dólar: lunes 13 de abril de 2026 https://t.co/Xpe91DalZb”, providing an update on the exchange rate between the US dollar and Costa Rican colón for that day.
La Nación has a longstanding reputation for investigative reporting in Costa Rica and frequently covers developments within public health institutions such as CCSS. The Social Security Fund is responsible for managing healthcare services nationwide and often faces challenges related to costs and patient access to medications. Additionally, oversight by bodies like the Colegio de Médicos ensures professional standards are maintained within the medical community.
